Action A042520 HANSBIOMED CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues HansBiomed Corporation

Actions

A042520

KR7042520007

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 01/07/2024 		Varia. 5j. Varia. 1 janv.
11 750 KRW +0,60 % Graphique intraday de HansBiomed Corporation -4,47 % -19,96 %
14/05 HansBiomed Corporation annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 mars 2024 CI
14/02 HansBiomed Corporation annonce ses résultats pour le premier trimestre clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023
HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation's Equity Buyback announced on June 23, 2022, has expired with 202,283 shares, representing 2.08% for KRW 1,986.65 million.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
HansBiomed Corporation(KOSDAQ:A042520) dropped from S&P Global BMI Index
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.
HansBiomed Corporation announces an Equity Buyback for KRW 2,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
HansBiomed Corporation announces an Equity Buyback for KRW 3,000 million worth of its shares.
HansBiomed Corporation authorizes a Buyback Plan.
HansBiomed Corporation Auditor Raises 'Going Concern' Doubt
HansBiomed Corporation announced that it has received KRW 15 billion in funding from Noh & Partners Corporation
Rebirth Biotechnology Co., Ltd announced that it has received CNY 20 million in funding from HansBiomed Corporation
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A042520
  4. Actualités HansBiomed Corporation
  5. Autres langues